GLOBAL STREP THROAT TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market News

Recent Developments:

New Product Launches & Approval:

In July 2022, Taiho Pharmaceutical Co., Ltd., a pharmaceutical company, launched PITAS throat troche series, film-type troches that stick to the roof of the mouth and are effective for throat pain and swelling, in Singapore

In September 2020, Taiho Pharmaceutical Co., Ltd., a pharmaceutical company, launched Pitas Throat Troche Orange and Pitas Throat Troche Lychee (designated quasi-drug), which are film-type troches that sticks to the roof of the mouth, throughout Japan. With the active ingredient cetylpyridinium chloride hydrate, Pitas Throat Troche is effective for sterilization/disinfection of the mouth and for throat pain and swelling due to inflammation of the throat.

Acquisition, Collaboration, Partnerships and investment/funding:

In March 2021, GSK plc, a pharmaceutical company, announced that it had received CARB-X, funding, a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria, to develop new vaccines to prevent serious infections caused by two different pathogens such as Group A Streptococcus (Strep A) infections, commonly known as Strep Throat by Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the US Department of Health and Human Services

In October 2020, Cure Kids, a New Zealand based largest charitable funder, announced that it had received US$ 3 Mn funding New Zealand government for development of strep throat vaccine, which could prevent rheumatic fever and rheumatic heart disease.